Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1989 Mar;83(3):836–843. doi: 10.1172/JCI113966

Systemic senile amyloidosis. Identification of a new prealbumin (transthyretin) variant in cardiac tissue: immunologic and biochemical similarity to one form of familial amyloidotic polyneuropathy.

P D Gorevic 1, F C Prelli 1, J Wright 1, M Pras 1, B Frangione 1
PMCID: PMC303756  PMID: 2646319

Abstract

Isolated amyloid fibrils from three cases of systemic senile amyloidosis (SSA) contained subunit proteins with molecular masses of 14 (10-20%), 10-12 (60-80%), and 5-6 kD (5-10%) when fractionated under reducing and dissociating conditions. This grouping was identical to that seen in SKO, a case of familial amyloidotic polyneuropathy (FAP) studied earlier. Amino acid sequencing confirmed that SSA subunit proteins were in fact prealbumin (transthyretin). Complete sequence analysis of one SSA preparation revealed the presence of a new variant Pa (TTr) molecule with a single amino acid substitution of isoleucine for valine at position 122. Further studies used an antiserum specific for SKO IV, a subunit protein of SKO previously shown to correspond to carboxy-terminal 78 residues (positions 49-127) of (TTr). Anti-SKO IV reacted with SSA in tissue at equivalent dilutions to anti-Pa (TTr) and with the 10-12-kD fraction of SSA on Western blots; reactivity was blocked by SKO IV, but not by Pa (TTr). SSA is a form of systemic amyloidosis caused by tissue deposition of Pa (TTr) and its fragments, with shared conformational or subunit antigenicity to at least one form of FAP. Identification of a new variant Pa (TTr) molecule in one case suggests further that SSA may be a genetically determined disease expressed late in life.

Full text

PDF
836

Images in this article

839Image
on p.839
840Image
on p.840
840Image
on p.840
840Image
on p.840
841Image
on p.841
841Image
on p.841
841Image
on p.841

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Axén R., Porath J., Ernback S. Chemical coupling of peptides and proteins to polysaccharides by means of cyanogen halides. Nature. 1967 Jun 24;214(5095):1302–1304. doi: 10.1038/2141302a0. [DOI] [PubMed] [Google Scholar]
  2. Benson M. D., Dwulet F. E. Prealbumin and retinol binding protein serum concentrations in the Indiana type hereditary amyloidosis. Arthritis Rheum. 1983 Dec;26(12):1493–1498. doi: 10.1002/art.1780261211. [DOI] [PubMed] [Google Scholar]
  3. Benson M. D., Wallace M. R., Tejada E., Baumann H., Page B. Hereditary amyloidosis: description of a new American kindred with late onset cardiomyopathy. Appalachian amyloid. Arthritis Rheum. 1987 Feb;30(2):195–200. doi: 10.1002/art.1780300210. [DOI] [PubMed] [Google Scholar]
  4. Connors L. H., Gertz M. A., Skinner M., Cohen A. S. Nephelometric measurement of human serum prealbumin and correlation with acute-phase proteins CRP and SAA: results in familial amyloid polyneuropathy. J Lab Clin Med. 1984 Oct;104(4):538–545. [PubMed] [Google Scholar]
  5. Cornwell G. G., 3rd, Murdoch W. L., Kyle R. A., Westermark P., Pitkänen P. Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation. Am J Med. 1983 Oct;75(4):618–623. doi: 10.1016/0002-9343(83)90443-6. [DOI] [PubMed] [Google Scholar]
  6. Cornwell G. G., 3rd, Westermark P., Natvig J. B., Murdoch W. Senile cardiac amyloid: evidence that fibrils contain a protein immunologically related to prealbumin. Immunology. 1981 Nov;44(3):447–452. [PMC free article] [PubMed] [Google Scholar]
  7. Dwulet F. E., Benson M. D. Characterization of a transthyretin (prealbumin) variant associated with familial amyloidotic polyneuropathy type II (Indiana/Swiss). J Clin Invest. 1986 Oct;78(4):880–886. doi: 10.1172/JCI112675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. FREDERIKSEN T., GOTZSCHE H., HARBOE N., KIAER W., MELLEMGAARD K. Familial primary amyloidosis with severe amyloid heart disease. Am J Med. 1962 Sep;33:328–348. doi: 10.1016/0002-9343(62)90230-9. [DOI] [PubMed] [Google Scholar]
  9. Felding P., Fex G., Westermark P., Olofsson B. O., Pitkänen P., Benson L. Prealbumin in Swedish patients with senile systemic amyloidosis and familial amyloidotic polyneuropathy. Scand J Immunol. 1985 Feb;21(2):133–140. doi: 10.1111/j.1365-3083.1985.tb01412.x. [DOI] [PubMed] [Google Scholar]
  10. Franklin E. C., Zucker-Franklin D. Antisera specific for human amyloid reactive with conformational antigens. Proc Soc Exp Biol Med. 1972 Jun;140(2):565–568. doi: 10.3181/00379727-140-36504. [DOI] [PubMed] [Google Scholar]
  11. Gorevic P. D., Rodrigues M. M., Krachmer J. H., Green C., Fujihara S., Glenner G. G. Lack of evidence for protein AA reactivity in amyloid deposits of lattice corneal dystrophy and amyloid corneal degeneration. Am J Ophthalmol. 1984 Aug 15;98(2):216–224. doi: 10.1016/0002-9394(87)90357-6. [DOI] [PubMed] [Google Scholar]
  12. Gorevic P. D., Rodrigues M. M., Spencer W. H., Munoz P. C., Allen A. W., Jr, Verne A. Z. Prealbumin. A major constituent of vitreous amyloid. Ophthalmology. 1987 Jul;94(7):792–798. doi: 10.1016/s0161-6420(87)33531-6. [DOI] [PubMed] [Google Scholar]
  13. Husby G., Ranløv P. J., Sletten K., Marhaug G. The amyloid in familial amyloid cardiomyopathy of Danish origin is related to pre-albumin. Clin Exp Immunol. 1985 Apr;60(1):207–216. [PMC free article] [PubMed] [Google Scholar]
  14. Ikeda S., Koh C. S., Miyasaka M., Yanagisawa N., Tsukagoshi H. [Familial amyloid neuropathy with late onset and benign course (author's transl)]. Rinsho Shinkeigaku. 1981 Feb;21(2):135–142. [PubMed] [Google Scholar]
  15. Kametani F., Tonoike H., Hoshi A., Shinoda T., Kito S. A variant prealbumin-related low molecular weight amyloid fibril protein in familial amyloid polyneuropathy of Japanese origin. Biochem Biophys Res Commun. 1984 Dec 14;125(2):622–628. doi: 10.1016/0006-291x(84)90584-9. [DOI] [PubMed] [Google Scholar]
  16. Kanda Y., Goodman D. S., Canfield R. E., Morgan F. J. The amino acid sequence of human plasma prealbumin. J Biol Chem. 1974 Nov 10;249(21):6796–6805. [PubMed] [Google Scholar]
  17. Libbey C. A., Rubinow A., Shirahama T., Deal C., Cohen A. S. Familial amyloid polyneuropathy. Demonstration of prealbumin in a kinship of German/English ancestry with onset in the seventh decade. Am J Med. 1984 Jan;76(1):18–24. doi: 10.1016/0002-9343(84)90739-3. [DOI] [PubMed] [Google Scholar]
  18. Linke R. P. Immunohistochemical identification and cross reactions of amyloid fibril proteins in senile heart and amyloid in familial polyneuropathy. Lack of reactivity with cerebral amyloid in Alzheimer's disease. Clin Neuropathol. 1982;1(4):172–182. [PubMed] [Google Scholar]
  19. Nakazato M., Kangawa K., Minamino N., Tawara S., Matsuo H., Araki S. Revised analysis of amino acid replacement in a prealbumin variant (SKO-III) associated with familial amyloidotic polyneuropathy of Jewish origin. Biochem Biophys Res Commun. 1984 Sep 28;123(3):921–928. doi: 10.1016/s0006-291x(84)80222-3. [DOI] [PubMed] [Google Scholar]
  20. Pepys M. B., Dash A. C. Isolation of amyloid P component (protein AP) from normal serum as a calcium-dependent binding protein. Lancet. 1977 May 14;1(8020):1029–1031. doi: 10.1016/s0140-6736(77)91260-0. [DOI] [PubMed] [Google Scholar]
  21. Pitkänen P., Westermark P., Cornwell G. G., 3rd Senile systemic amyloidosis. Am J Pathol. 1984 Dec;117(3):391–399. [PMC free article] [PubMed] [Google Scholar]
  22. Pras M., Franklin E. C., Prelli F., Frangione B. A variant of prealbumin from amyloid fibrils in familial polyneuropathy of Jewish origin. J Exp Med. 1981 Sep 1;154(3):989–993. doi: 10.1084/jem.154.3.989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Pras M., Prelli F., Franklin E. C., Frangione B. Primary structure of an amyloid prealbumin variant in familial polyneuropathy of Jewish origin. Proc Natl Acad Sci U S A. 1983 Jan;80(2):539–542. doi: 10.1073/pnas.80.2.539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Pras M., Schubert M., Zucker-Franklin D., Rimon A., Franklin E. C. The characterization of soluble amyloid prepared in water. J Clin Invest. 1968 Apr;47(4):924–933. doi: 10.1172/JCI105784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Raz A., Goodman D. S. The interaction of thyroxine with human plasma prealbumin and with the prealbumin-retinol-binding protein complex. J Biol Chem. 1969 Jun 25;244(12):3230–3237. [PubMed] [Google Scholar]
  26. Richardson J. S. The anatomy and taxonomy of protein structure. Adv Protein Chem. 1981;34:167–339. doi: 10.1016/s0065-3233(08)60520-3. [DOI] [PubMed] [Google Scholar]
  27. Sandgren O., Westermark P., Stenkula S. Relation of vitreous amyloidosis to prealbumin. Ophthalmic Res. 1986;18(2):98–103. doi: 10.1159/000265422. [DOI] [PubMed] [Google Scholar]
  28. Saraiva M. J., Birken S., Costa P. P., Goodman D. S. Amyloid fibril protein in familial amyloidotic polyneuropathy, Portuguese type. Definition of molecular abnormality in transthyretin (prealbumin). J Clin Invest. 1984 Jul;74(1):104–119. doi: 10.1172/JCI111390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Skinner M., Cohen A. S. The prealbumin nature of the amyloid protein in familial amyloid polyneuropathy (FAP)-swedish variety. Biochem Biophys Res Commun. 1981 Apr 30;99(4):1326–1332. doi: 10.1016/0006-291x(81)90764-6. [DOI] [PubMed] [Google Scholar]
  30. Skinner M., Shirahama T., Cohen A. S., Deal C. L. The association of amyloid P-component (AP) with the amyloid fibril: an updated method for amyloid fibril protein isolation. Prep Biochem. 1982;12(5):461–476. doi: 10.1080/10826068208070597. [DOI] [PubMed] [Google Scholar]
  31. Sletten K., Westermark P., Natvig J. B. Senile cardiac amyloid is related to prealbumin. Scand J Immunol. 1980;12(6):503–506. doi: 10.1111/j.1365-3083.1980.tb00098.x. [DOI] [PubMed] [Google Scholar]
  32. Solomon A., Frangione B., Franklin E. C. Bence Jones proteins and light chains of immunoglobulins. Preferential association of the V lambda VI subgroup of human light chains with amyloidosis AL (lambda). J Clin Invest. 1982 Aug;70(2):453–460. doi: 10.1172/JCI110635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Sternberger L. A., Hardy P. H., Jr, Cuculis J. J., Meyer H. G. The unlabeled antibody enzyme method of immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes. J Histochem Cytochem. 1970 May;18(5):315–333. doi: 10.1177/18.5.315. [DOI] [PubMed] [Google Scholar]
  34. Swank R. T., Munkres K. D. Molecular weight analysis of oligopeptides by electrophoresis in polyacrylamide gel with sodium dodecyl sulfate. Anal Biochem. 1971 Feb;39(2):462–477. doi: 10.1016/0003-2697(71)90436-2. [DOI] [PubMed] [Google Scholar]
  35. Tawara S., Nakazato M., Kangawa K., Matsuo H., Araki S. Identification of amyloid prealbumin variant in familial amyloidotic polyneuropathy (Japanese type). Biochem Biophys Res Commun. 1983 Nov 15;116(3):880–888. doi: 10.1016/s0006-291x(83)80224-1. [DOI] [PubMed] [Google Scholar]
  36. Wallace M. R., Dwulet F. E., Conneally P. M., Benson M. D. Biochemical and molecular genetic characterization of a new variant prealbumin associated with hereditary amyloidosis. J Clin Invest. 1986 Jul;78(1):6–12. doi: 10.1172/JCI112573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Westermark P., Natvig J. B., Johansson B. Characterization of an amyloid fibril protein from senile cardiac amyloid. J Exp Med. 1977 Aug 1;146(2):631–636. doi: 10.1084/jem.146.2.631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Westermark P., Pitkänen P., Benson L., Vahlquist A., Olofsson B. O., Cornwell G. G., 3rd Serum prealbumin and retinol-binding protein in the prealbumin-related senile and familial forms of systemic amyloidosis. Lab Invest. 1985 Mar;52(3):314–318. [PubMed] [Google Scholar]
  39. Wright J. R., Calkins E. Amyloid in the aged heart: frequency and clinical significance. J Am Geriatr Soc. 1975 Mar;23(3):97–103. doi: 10.1111/j.1532-5415.1975.tb00968.x. [DOI] [PubMed] [Google Scholar]
  40. Wright J. R., Calkins E. Clinical-pathologic differentiation of common amyloid syndromes. Medicine (Baltimore) 1981 Nov;60(6):429–448. doi: 10.1097/00005792-198111000-00004. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES